OrbiMed Advisors LLC
- SEC CIK
- 0001055951
In the past year, 6 open-market purchase filings worth $85.9M and 6 sale filings worth $63.0M.
Current role at each company
- ETRA Electra Therapeutics, Inc.Director, 10% Owneras of Sep 23, 2026
- BLSM BlossomHill Therapeutics, Inc.Directoras of Aug 12, 2026
- BRVE Braveheart Bio, Inc.Director, 10% Owneras of Aug 11, 2026
- SCTX Scribe Therapeutics, Inc.Directoras of Jul 29, 2026
- SION Sionna Therapeutics, Inc.Directoras of Jul 9, 2026
Show 39 more companies
- ELVN Enliven Therapeutics, Inc.10% Owneras of Jun 24, 2026
- STTK Shattuck Labs, Inc.Directoras of Jun 15, 2026
- QTTB Q32 Bio Inc.Director, 10% Owneras of Jun 1, 2026
- TRAW Traws Pharma, Inc.10% Owneras of Apr 28, 2026
- PRLD Prelude Therapeutics IncDirector, 10% Owneras of Apr 23, 2026
- IMA ImageneBio, Inc.Directoras of Apr 16, 2026
- ACET Adicet Bio, Inc.10% Owneras of Apr 9, 2026
- KROS Keros Therapeutics, Inc.Directoras of Dec 18, 2025
- PMVP PMV Pharmaceuticals, Inc.10% Owneras of Oct 27, 2025
- TSBX Turnstone Biologics Corp.Directoras of Aug 12, 2025
- CRVS Corvus Pharmaceuticals, Inc.Director, 10% Owneras of Jul 1, 2025
- PASG Passage BIO, Inc.10% Owneras of Jun 26, 2025
- NPCE NeuroPace Inc10% Owneras of May 16, 2025
- XTNT Xtant Medical Holdings, Inc.10% Owneras of Apr 14, 2025
- CMPX Compass Therapeutics, Inc.Director, 10% Owneras of Apr 11, 2025
- EWTX Edgewise Therapeutics, Inc.Director, 10% Owneras of Apr 4, 2025
- IRON Disc Medicine, Inc.Directoras of Mar 26, 2025
- MBX MBX Biosciences, Inc.Director, 10% Owneras of Feb 19, 2025
- Lomond Therapeutics Holdings, Inc.Directoras of Nov 5, 2024
- UPB Upstream Bio, Inc.Director, 10% Owneras of Oct 17, 2024
- SPRY ARS Pharmaceuticals, Inc.Directoras of Aug 28, 2024
- SCPH scPharmaceuticals Inc.10% Owneras of Aug 15, 2024
- TERN Terns Pharmaceuticals, Inc.Director, 10% Owneras of Jul 17, 2024
- TELA TELA Bio, Inc.10% Owneras of Jul 2, 2024
- ALPN Alpine Immune Sciences, Inc.Directoras of May 20, 2024
- KNTE Kinnate Biopharma Inc.Director, 10% Owneras of Apr 5, 2024
- THRX Theseus Pharmaceuticals, Inc.Director, 10% Owneras of Feb 14, 2024
- AVBP ArriVent BioPharma, Inc.Director, 10% Owneras of Jan 31, 2024
- DMRA Damora Therapeutics, Inc.10% Owneras of Aug 17, 2023
- VRNA Verona Pharma plcDirectoras of May 15, 2023
- TCDA Tricida, Inc.Director, 10% Owneras of Nov 25, 2022
- THRD Third Harmonic Bio, Inc.Director, 10% Owneras of Sep 21, 2022
- SWTX SpringWorks Therapeutics, Inc.10% Owneras of Sep 14, 2022
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
- ARQT Arcutis Biotherapeutics, Inc.10% Owneras of Jun 28, 2022
- ETNB 89bio, Inc.10% Owneras of Jan 27, 2022
- JANX Janux Therapeutics, Inc.Directoras of Dec 30, 2021
- RPTX Repare Therapeutics Inc.Directoras of Sep 8, 2021
- AFIB Acutus Medical, Inc.Director, 10% Owneras of Jul 21, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $85.9M
- 6 filings
- Sold
- $63.0M
- 6 filings
- Net
- +$22.9M
- Bought minus sold
- Companies
- 9
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Advisors LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ETRA Electra Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)5:29 PM ET | Sep 21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +313.8%1.76M after | 2 lots |
BLSM BlossomHill Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 (view filing)4:43 PM ET | Aug 10 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | PPurchase | +625.0K | $16.00 | +$10.0M | +29.9%2.71M after |
BRVE Braveheart Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)5:27 PM ET | Aug 7 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.94M | $18.00 | +$34.9M | New position273.3K after | 2 lots |
SCTX Scribe Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 (view filing)6:47 PM ET | Jul 27 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | PPurchase | +1.00M | $15.00 | +$15.0M | +286.7%1.35M after |
SION Sionna Therapeutics, Inc.
Director11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 (view filing)4:28 PM ET | Feb 10 | Same day | OrbiMed Advisors LLC and 1 otherDirector | PPurchase | +550.0K | $18.00 | +$9.90M | +17.4%3.70M after | Duplicate filing |
| Nov 26, 2025 (view filing)6:45 PM ET | Nov 24-26 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −108.1K | $44.55 | −$4.81M | −2.9%3.60M after | 3 lots10b5-1Duplicate filing |
| Dec 19, 2025 (view filing)7:29 PM ET | Dec 17-19 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −1.88K | $44.49 | −$83.4K | −0.1%3.60M after | 3 lots10b5-1Duplicate filing |
| Dec 29, 2025 (view filing)8:44 PM ET | Dec 24 | 5 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −33.4K | $44.55 | −$1.49M | −0.9%3.56M after | 10b5-1Duplicate filing |
| Feb 4, 2026 (view filing)7:39 PM ET | Feb 2-3 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −31.0K | $44.58 | −$1.38M | −0.9%3.53M after | 2 lots10b5-1Duplicate filing |
| Apr 16, 2026 (view filing)7:03 PM ET | Apr 14-16 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −510.6K | $44.94 | −$22.9M | −14.5%3.02M after | 3 lots10b5-1Duplicate filing |
| Apr 21, 2026 (view filing)8:40 PM ET | Apr 17-18 | 4 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −55.3K | $44.67 | −$2.47M | −1.8%2.96M after | 2 lots10b5-1Duplicate filing |
| May 11, 2026 (view filing)6:58 PM ET | May 7-11 | 4 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −293.0K | $45.62 | −$13.4M | −9.9%2.67M after | 3 lots10b5-1Duplicate filing |
| May 29, 2026 (view filing)8:57 PM ET | May 27 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −101 | $44.49 | −$4.49K | 0.0%2.67M after | 10b5-1Duplicate filing |
| Jul 2, 2026 (view filing)4:42 PM ET | Jun 30 | 2 days | OrbiMed Advisors LLC and 1 otherDirector | SSale | −115.8K | $45.50 | −$5.27M | −4.3%2.56M after | 10b5-1 |
ELVN Enliven Therapeutics, Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing)4:27 PM ET | Jul 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | New position1.67M after | |
| Jul 23, 2021 (view filing)5:30 PM ET | Jul 16 | 7 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | +65.8%4.20M after | AmendedDuplicate filing |
| May 20, 2024 (view filing)5:00 PM ET | May 16 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −1.03M | $22.14 | −$22.9M | −11.9%7.66M after | 2 lotsDuplicate filing |
| Jun 17, 2026 (view filing)7:45 PM ET | Jun 15 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −281.4K | $45.02 | −$12.7M | −3.7%7.39M after | 2 lots |
| Jun 24, 2026 (view filing)7:19 PM ET | Jun 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −860.1K | $45.36 | −$39.0M | −11.6%6.56M after | 4 lots |
STTK Shattuck Labs, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 (view filing)9:52 PM ET | Aug 25 | 8 daysLate | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +6.31M | $0.8677 | +$5.47M | New position1.05M after | 2 lots |
| Sep 2, 2025 (view filing)9:52 PM ET | Aug 25 | 8 daysLate | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +30.6M | – | – | –3.07M after | Derivative4 lotsDuplicate filing |
| Jun 15, 2026 (view filing)6:12 PM ET | Jun 11 | 4 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +1.25M | – | – | –5.30M after | Derivative2 lotsDuplicate filing |
QTTB Q32 Bio Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 (view filing)9:13 PM ET | May 28 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.88M | $8.00 | +$15.0M | New position625.0K after | 2 lotsDuplicate filing |
TRAW Traws Pharma, Inc.
10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 (view filing)7:03 PM ET | Dec 29, 2024 | 29 daysLate | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +192.7K | – | – | –96.3K after | Derivative2 lotsDuplicate filing |
| Apr 28, 2026 (view filing)9:41 PM ET | Apr 16 | 12 daysLate | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +597.7K | $1.67 | +$998.2K | +98.7%1.20M after | |
| Apr 28, 2026 (view filing)9:41 PM ET | Apr 16 | 12 daysLate | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +2.99M | – | – | –1.79M after | Derivative3 lots |
PRLD Prelude Therapeutics Inc
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 (view filing)5:09 PM ET | May 22 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +869.6K | $5.75 | +$5.00M | +9.4%10.1M after | Duplicate filing |
| Apr 23, 2026 (view filing)6:48 PM ET | Apr 21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +2.82M | $4.44 | +$12.5M | New position1.13M after | 2 lotsDuplicate filing |
IMA ImageneBio, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2022 (view filing)5:39 PM ET | Jun 22-24 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | −252.2K | $4.47 | −$1.13M | −10.7%2.10M after | 4 lotsDuplicate filing |
| Apr 16, 2026 (view filing)7:23 PM ET | Apr 14 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | PPurchase | +721.3K | – | – | –384.7K after | Derivative2 lotsDuplicate filing |
ACET Adicet Bio, Inc.
10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2023 (view filing)4:46 PM ET | Jun 27 | 2 days | OrbiMed Advisors LLC and 8 othersDirector, 10% Owner | PPurchase | +875.0K | $2.09 | +$1.83M | New position748.1K after | 4 lotsDuplicate filing |
| Jan 26, 2024 (view filing)7:14 PM ET | Jan 25 | 1 day | OrbiMed Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +3.13M | $2.40 | +$7.50M | New position1.26M after | 3 lotsDuplicate filing |
| Oct 10, 2025 (view filing)8:06 PM ET | Oct 8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | PPurchase | +5.00M | $1.00 | +$5.00M | New position4.49M after | 2 lots |
| Apr 9, 2026 (view filing)5:38 PM ET | Apr 7-8 | 2 days | OrbiMed Advisors LLC and 7 others10% Owner | SSale | −104.7K | $6.45 | −$674.8K | −100.0%0 after | 4 lots |
PMVP PMV Pharmaceuticals, Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 (view filing)5:30 PM ET | Mar 29-31 | 2 days | OrbiMed Advisors LLC and 3 others10% Owner | SSale | −474.5K | $21.63 | −$10.3M | −100.0%0 after | 3 lots |
| May 31, 2022 (view filing)4:36 PM ET | May 26 | 5 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −26.3K | $15.93 | −$418.2K | −23.0%87.8K after | |
| Nov 24, 2023 (view filing)4:38 PM ET | Nov 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −87.8K | $2.23 | −$195.8K | −100.0%0 after | |
| Sep 12, 2025 (view filing)5:09 PM ET | Sep 10 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −500.0K | $1.80 | −$900.0K | −7.7%5.98M after | |
| Oct 27, 2025 (view filing)5:19 PM ET | Oct 23 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −1.00M | $1.52 | −$1.52M | −16.7%4.98M after |
CRVS Corvus Pharmaceuticals, Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2021 (view filing)5:27 PM ET | Sep 20 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | SSaleCommon Stock, $0.0001 par value | −1.11M | $6.09 | −$6.76M | −13.8%6.94M after | Duplicate filing |
| May 8, 2024 (view filing)8:28 PM ET | May 6 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +2.84M | $1.73 | +$2.50M | –1.40M after | Derivative2 lots |
| Jul 1, 2025 (view filing)9:23 PM ET | Jun 27 | 4 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | SSale | −1.18M | $4.16 | −$4.89M | −14.1%7.17M after |
PASG Passage BIO, Inc.
10% Owner15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing)7:37 PM ET | Jan 11-13 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +150.0K | $5.61 | +$841.1K | +2.5%6.10M after | 3 lots |
| Jan 20, 2022 (view filing)6:03 PM ET | Jan 14-19 | 6 daysLate | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +168.3K | $5.38 | +$905.2K | +2.8%6.27M after | 3 lots |
| May 5, 2022 (view filing)5:11 PM ET | Jan 20 | 105 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +50.8K | $5.00 | +$254.0K | +0.8%6.32M after | Amended |
| May 5, 2022 (view filing)5:23 PM ET | May 3-4 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +525.0K | $1.94 | +$1.02M | +8.3%6.84M after | 2 lots |
| Jun 29, 2023 (view filing)4:42 PM ET | Jun 27-28 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +1.19M | $0.84 | +$1.00M | +17.4%8.03M after | 2 lots |
| Sep 18, 2024 (view filing)6:38 PM ET | Sep 16-18 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −200.1K | $0.7332 | −$146.7K | −2.5%7.83M after | 3 lots |
| Sep 23, 2024 (view filing)4:51 PM ET | Sep 19 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −39.3K | $0.71 | −$27.9K | −0.5%7.79M after | |
| Dec 6, 2024 (view filing)7:07 PM ET | Dec 4-6 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −97.1K | $0.7965 | −$77.3K | −1.2%7.70M after | 2 lots |
| Dec 11, 2024 (view filing)5:32 PM ET | Dec 9-11 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −62.3K | $0.8348 | −$52.0K | −0.8%7.64M after | 3 lots |
| Dec 26, 2024 (view filing)4:34 PM ET | Dec 20 | 6 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −230.3K | $0.60 | −$138.2K | −3.0%7.40M after |
NPCE NeuroPace Inc
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 (view filing)5:36 PM ET | Oct 2-3 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −8.31K | $9.07 | −$75.4K | −0.2%4.00M after | 2 lots |
| Apr 15, 2024 (view filing)5:25 PM ET | Apr 11-12 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −485.0K | $14.49 | −$7.03M | −12.1%3.52M after | 2 lots |
| Apr 18, 2024 (view filing)5:10 PM ET | Apr 16-18 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −17.0K | $14.02 | −$238.2K | −0.5%3.50M after | 3 lots |
| Apr 23, 2024 (view filing)6:38 PM ET | Apr 19-23 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −64.7K | $14.12 | −$913.1K | −1.8%3.44M after | 3 lots |
| Apr 26, 2024 (view filing)5:01 PM ET | Apr 24 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −1.78K | $14.06 | −$25.0K | −0.1%3.44M after | |
| May 3, 2024 (view filing)5:16 PM ET | May 1-3 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −29.2K | $14.02 | −$409.4K | −0.9%3.41M after | 3 lots |
| May 16, 2025 (view filing)5:26 PM ET | May 14 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −168.1K | $15.85 | −$2.67M | −4.9%3.24M after | 2 lots |
XTNT Xtant Medical Holdings, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2025 (view filing)7:14 PM ET | Apr 10 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −73.1M | $0.42 | −$30.7M | −100.0%0 after | 2 lots |
CMPX Compass Therapeutics, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2021 (view filing)9:06 PM ET | Nov 4 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +5.36M | $3.50 | +$18.8M | New position3.57M after | 2 lotsDuplicate filing |
| May 10, 2022 (view filing)6:21 PM ET | May 6-10 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +125.4K | $1.57 | +$197.3K | +0.9%14.6M after | 3 lotsDuplicate filing |
| May 13, 2022 (view filing)5:45 PM ET | May 11-13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +192.5K | $2.18 | +$420.5K | +1.3%14.8M after | 3 lotsDuplicate filing |
| Nov 10, 2022 (view filing)4:44 PM ET | Nov 8 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +402.0K | $3.21 | +$1.29M | +2.7%15.2M after | Duplicate filing |
| Apr 11, 2025 (view filing)7:24 PM ET | Apr 9 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −3.57M | $1.59 | −$5.68M | −100.0%0 after | Duplicate filing |
EWTX Edgewise Therapeutics, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 (view filing)4:38 PM ET | May 18 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +138.0K | $7.21 | +$995.0K | +1.0%13.5M after | Duplicate filing |
| Sep 16, 2022 (view filing)4:31 PM ET | Sep 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +484.5K | $10.32 | +$5.00M | +3.6%14.0M after | Duplicate filing |
| Jan 25, 2024 (view filing)4:28 PM ET | Jan 23 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +454.5K | $11.00 | +$5.00M | +3.3%14.4M after | Duplicate filing |
| Apr 4, 2025 (view filing)7:33 PM ET | Apr 3 | 1 day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +496.8K | $20.13 | +$10.0M | New position443.8K after | 2 lotsDuplicate filing |
IRON Disc Medicine, Inc.
Director8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 (view filing)4:43 PM ET | Feb 15 | 2 days | OrbiMed Advisors LLC and 3 othersDirector, 10% Owner | PPurchase | +108.7K | $23.00 | +$2.50M | +57.1%299.2K after | 3 lotsDuplicate filing |
| Dec 14, 2023 (view filing)5:44 PM ET | Dec 12-14 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −134.2K | $58.88 | −$7.90M | −15.6%727.8K after | 8 lotsDuplicate filing |
| Dec 15, 2023 (view filing)6:04 PM ET | Dec 14 | 1 day | OrbiMed Advisors LLC and 3 othersDirector | SSale | −433.2K | $56.75 | −$24.6M | −65.9%224.4K after | 3 lotsDuplicate filing |
| Dec 20, 2023 (view filing)6:28 PM ET | Dec 18 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −1.72K | $59.24 | −$102.1K | −100.0%0 after | Duplicate filing |
| Jun 20, 2024 (view filing)5:19 PM ET | Jun 17 | 3 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +83.3K | $36.00 | +$3.00M | +54.8%235.4K after | 3 lotsDuplicate filing |
| Mar 12, 2025 (view filing)9:34 PM ET | Mar 10-12 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −312.4K | $54.31 | −$17.0M | −61.7%194.2K after | 15 lotsDuplicate filing |
| Mar 21, 2025 (view filing)8:00 PM ET | Mar 19-21 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −52.4K | $54.02 | −$2.83M | −21.9%187.3K after | 9 lotsDuplicate filing |
| Mar 26, 2025 (view filing)7:00 PM ET | Mar 24 | 2 days | OrbiMed Advisors LLC and 3 othersDirector | SSale | −5.74K | $54.11 | −$310.5K | −3.0%186.5K after | 3 lotsDuplicate filing |